CTKB

Cytek Biosciences
$4.41
−$0.05 (−1.12%)Jul 27, 2026
4.5NeutralMoatMint rating

MoatMint rates Cytek Biosciences (CTKB) 4.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 4.6 out of 10.

Key metrics

The numbers that frame CTKB today
Market cap
$569.52M
P/E (TTM)
-7.7
EV / FCF
-41.1
Gross margin
51.7%
EV / Sales
2.5
ROIC
-12.3%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.28
52wk High
$6.18

CTKB stock rating

How CTKB scores on quality, value, growth, momentum and financial health
4.5out of 10
Neutral overallHealthy business, expensive priceTop 55% of ~5,000 US stocks
QualityNeutral4.6/10
GrowthGood6.7/10
MomentumGood6.1/10
ValueFair3.1/10
Financial HealthFair3.9/10

Growth

Revenue and earnings trend for CTKB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CTKB
Is Cytek Biosciences a good buy?
Hold. Cytek Biosciences has mixed quality and strong momentum. The setup is mixed. Growth looks strong, which supports the long-term business case. We think Cytek Biosciences is selling at a high price.
What is the market capitalization of CTKB?
Cytek Biosciences's market capitalization is $569.52M.
What is the P/E ratio for CTKB stock?
Cytek Biosciences's current P/E ratio is -7.7.
What is the 52-week high for CTKB stock?
The 52-week high for Cytek Biosciences is $6.18. The current close of $4.41 is 28.6% below that high.
What is the 52-week low for CTKB stock?
The 52-week low for Cytek Biosciences is $3.28. The current close of $4.41 is 34.5% above that low.
Does CTKB stock pay dividends?
Cytek Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTKB?
Cytek Biosciences's Debt / Equity ratio is 0.04.